GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells (original) (raw)

• Abourbih DA, Di CS, Orellana ME, Antecka E, Martins C, Petruccelli LA et al. (2010). Lysyl oxidase expression and inhibition in uveal melanoma. Melanoma Res 20: 97–106.
  Article CAS PubMed Google Scholar
• Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC et al. (2007). Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9: 201–209.
  Article CAS PubMed Google Scholar
• Barkan D, El Touny LH, Michalowski AM, Smith JA, Chu I, Davis AS et al. (2010). Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res 70: 5706–5716.
  Article CAS PubMed PubMed Central Google Scholar
• Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, Hoenorhoff MJ et al. (2008). Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 68: 6241–6250.
  Article CAS PubMed PubMed Central Google Scholar
• Bondareva A, Downey CM, Ayres F, Liu W, Boyd SK, Hallgrimsson B et al. (2009). The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells. PLoS One 4: e5620–e562.
  Article PubMed PubMed Central Google Scholar
• Chu I, Blackwell K, Chen S, Slingerland J . (2005). The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer. Cancer Res 65: 18–25.
  CAS PubMed Google Scholar
• Condeelis J, Pollard JW . (2006). Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124: 263–266.
  Article CAS PubMed Google Scholar
• Dydensborg AB, Rose AA, Wilson BJ, Grote D, Paquet M, Giguere V et al. (2009). GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis. Oncogene 28: 2634–2642.
  Article CAS PubMed Google Scholar
• Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A et al. (2009). Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15: 35–44.
  Article CAS PubMed PubMed Central Google Scholar
• Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT et al. (2006). Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440: 1222–1226.
  Article CAS PubMed Google Scholar
• Grimsby JL, Lucero HA, Trackman PC, Ravid K, Kagan HM . (2010). Role of lysyl oxidase propeptide in secretion and enzyme activity. J Cell Biochem 111: 1231–1243.
  Article CAS PubMed Google Scholar
• Gupta GP, Massague J . (2006). Cancer metastasis: building a framework. Cell 127: 679–695.
  Article CAS PubMed Google Scholar
• Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS et al. (2009). Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69: 4116–4124.
  Article CAS PubMed PubMed Central Google Scholar
• Hoenerhoff MJ, Chu I, Barkan D, Liu ZY, Datta S, Dimri GP et al. (2009). BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases. Oncogene 28: 3022–3032.
  Article CAS PubMed PubMed Central Google Scholar
• Kagan HM, Li W . (2003). Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem 88: 660–672.
  Article CAS PubMed Google Scholar
• Kaneda A, Wakazono K, Tsukamoto T, Watanabe N, Yagi Y, Tatematsu M et al. (2004). Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer Res 64: 6410–6415.
  Article CAS PubMed Google Scholar
• Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ et al. (2008). GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 13: 141–152.
  Article CAS PubMed PubMed Central Google Scholar
• Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z . (2006a). GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127: 1041–1055.
  Article CAS PubMed PubMed Central Google Scholar
• Kouros-Mehr H, Werb Z . (2006b). Candidate regulators of mammary branching morphogenesis identified by genome-wide transcript analysis. Dev Dyn 235: 3404–3412.
  Article CAS PubMed PubMed Central Google Scholar
• Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT et al. (2009). Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139: 891–906.
  Article CAS PubMed PubMed Central Google Scholar
• Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD et al. (2005). Genes that mediate breast cancer metastasis to lung. Nature 436: 518–524.
  Article CAS PubMed PubMed Central Google Scholar
• Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T et al. (2006). A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515–527.
  Article CAS PubMed PubMed Central Google Scholar
• Palamakumbura AH, Trackman PC . (2002). A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples. Anal Biochem 300: 245–251.
  Article CAS PubMed Google Scholar
• Palamakumbura AH, Vora SR, Nugent MA, Kirsch KH, Sonenshein GE, Trackman PC . (2009). Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling. Oncogene 28: 3390–3400.
  Article CAS PubMed PubMed Central Google Scholar
• Payne SL, Fogelgren B, Hess AR, Seftor EA, Wiley EL, Fong SF et al. (2005). Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res 65: 11429–11436.
  Article CAS PubMed Google Scholar
• Payne SL, Hendrix MJ, Kirschmann DA . (2007). Paradoxical roles for lysyl oxidases in cancer—a prospect. J Cell Biochem 101: 1338–1354.
  Article CAS PubMed Google Scholar
• Perou CM, Sorlie T, Eisen MB, van de RM, Jeffrey SS, Rees CA et al. (2000). Molecular portraits of human breast tumours. Nature 406: 747–752.
  Article CAS PubMed Google Scholar
• Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A et al. (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100: 8418–8423.
  Article CAS PubMed PubMed Central Google Scholar
• Usary J, Llaca V, Karaca G, Presswala S, Karaca M, He X et al. (2004). Mutation of GATA3 in human breast tumors. Oncogene 23: 7669–7678.
  Article CAS PubMed Google Scholar
• van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW et al. (2002). A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999–2009.
  Article CAS PubMed Google Scholar
• van't Veer LJ, Dai H, van d V, He YD, Hart AA, Mao M et al. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530–536.
  Article CAS Google Scholar
• Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F et al. (2005). Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671–679.
  Article CAS PubMed Google Scholar
• Yan W, Cao QJ, Arenas RB, Bentley B, Shao R . (2010). GATA3 inhibits breast cancer metastasis through the reversal of epithelial–mesenchymal transition. J Biol Chem 285: 14042–14051.
  Article CAS PubMed PubMed Central Google Scholar
• Zhou M, Ouyang W . (2003). The function role of GATA-3 in Th1 and Th2 differentiation. Immunol Res 28: 25–37.
  Article CAS PubMed Google Scholar